603676 卫信康
已收盘 12-15 15:00:00
资讯
新帖
简况
卫信康(603676.SH)：利多卡因丁卡因乳膏获药物临床试验批准
智通财经 · 12-03
卫信康(603676.SH)：利多卡因丁卡因乳膏获药物临床试验批准
每周股票复盘：卫信康（603676）每股派现0.147元
证券之星 · 11-23
每周股票复盘：卫信康（603676）每股派现0.147元
卫信康（603676）披露2025年前三季度权益分派实施公告，11月18日股价下跌0.61%
证券之星 · 11-18
卫信康（603676）披露2025年前三季度权益分派实施公告，11月18日股价下跌0.61%
每周股票复盘：卫信康（603676）拟每10股派1.47元
证券之星 · 11-09
每周股票复盘：卫信康（603676）拟每10股派1.47元
股市必读：卫信康（603676）11月6日披露最新机构调研信息
证券之星 · 11-07
股市必读：卫信康（603676）11月6日披露最新机构调研信息
每周股票复盘：卫信康（603676）股东户数增14.14%，Q3净利降54.4%
证券之星 · 11-02
每周股票复盘：卫信康（603676）股东户数增14.14%，Q3净利降54.4%
股市必读：卫信康（603676）10月30日收盘跌7.13%，主力净流出1080.49万元
证券之星 · 10-31
股市必读：卫信康（603676）10月30日收盘跌7.13%，主力净流出1080.49万元
卫信康（603676）2025年三季报简析：净利润同比下降9.9%，盈利能力上升
证券之星 · 10-31
卫信康（603676）2025年三季报简析：净利润同比下降9.9%，盈利能力上升
图解卫信康三季报：第三季度单季净利润同比下降54.40%
证券之星 · 10-29
图解卫信康三季报：第三季度单季净利润同比下降54.40%
卫信康(603676)9月30日股东户数1.65万户，较上期增加14.14%
证券之星 · 10-29
卫信康(603676)9月30日股东户数1.65万户，较上期增加14.14%
每周股票复盘：卫信康（603676）2025年中期分红待定，上半年净利增11.82%
证券之星 · 09-14
每周股票复盘：卫信康（603676）2025年中期分红待定，上半年净利增11.82%
每周股票复盘：卫信康（603676）Q2净利增43.33%
证券之星 · 08-31
每周股票复盘：卫信康（603676）Q2净利增43.33%
股市必读：卫信康中报 - 第二季度单季净利润同比增长43.33%
证券之星 · 08-29
股市必读：卫信康中报 - 第二季度单季净利润同比增长43.33%
图解卫信康中报：第二季度单季净利润同比增长43.33%
证券之星 · 08-28
图解卫信康中报：第二季度单季净利润同比增长43.33%
卫信康：公司不涉及高反药相关业务
互动易 · 07-24
卫信康：公司不涉及高反药相关业务
卫信康股价回调1.37% 化学制药板块成交额达1.84亿元
金融界 · 07-15
卫信康股价回调1.37% 化学制药板块成交额达1.84亿元
每周股票复盘：卫信康（603676）因价格振幅达15%再次上榜龙虎榜
证券之星 · 07-13
每周股票复盘：卫信康（603676）因价格振幅达15%再次上榜龙虎榜
卫信康：公司将进一步增强自主创新研发能力，加强技术积累，形成差异化、高壁垒的产品群
互动易 · 07-11
卫信康：公司将进一步增强自主创新研发能力，加强技术积累，形成差异化、高壁垒的产品群
卫信康：公司始终坚持关爱生命维护健康的企业使命
互动易 · 07-10
卫信康：公司始终坚持关爱生命维护健康的企业使命
卫信康：2025年中期利润分配方案将根据条件制定
证券之星 · 07-10
卫信康：2025年中期利润分配方案将根据条件制定
公司概况
公司名称：
西藏卫信康医药股份有限公司
所属行业：
医药制造业
上市日期：
2017-07-21
主营业务：
西藏卫信康医药股份有限公司的主营业务是化学药品制剂及其原料药的研发、生产、销售。公司的主要产品是注射用多种维生素（12）、多种微量元素注射液、小儿多种维生素注射液（13）。
发行价格：
5.53
{"stockData":{"symbol":"603676","market":"SH","secType":"STK","nameCN":"卫信康","latestPrice":10.69,"timestamp":1765782000000,"preClose":10.77,"halted":0,"volume":1427300,"delay":0,"changeRate":-0.0074,"floatShares":434999999,"shares":434999999,"eps":0.5104,"marketStatus":"已收盘","change":-0.08,"latestTime":"12-15 15:00:00","open":10.67,"high":10.78,"low":10.65,"amount":15286100,"amplitude":0.0121,"askPrice":10.7,"askSize":160,"bidPrice":10.69,"bidSize":21,"shortable":0,"etf":0,"ttmEps":0.5104,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765848600000},"marketStatusCode":5,"adr":0,"adjPreClose":10.77,"symbolType":"stock","openAndCloseTimeList":[[1765762200000,1765769400000],[1765774800000,1765782000000]],"highLimit":11.85,"lowLimit":9.69,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":435161500,"isCdr":false,"pbRate":3.05,"roa":"--","peRate":20.944357,"roe":"15.01%","epsLYR":0.57,"committee":0.699248,"marketValue":4652000000,"turnoverRate":0.0033,"status":1,"floatMarketCap":4652000000},"requestUrl":"/m/hq/s/603676/wiki","defaultTab":"wiki","newsList":[{"id":"2588015850","title":"卫信康(603676.SH)：利多卡因丁卡因乳膏获药物临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2588015850","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588015850?lang=zh_cn&edition=full","pubTime":"2025-12-03 15:43","pubTimestamp":1764747793,"startTime":"0","endTime":"0","summary":"利多卡因丁卡因乳膏由Zars公司研发，在2006年6月29日获美国FDA批准，商品名为Pliaglis，规格为每g含利多卡因70mg与丁卡因70mg。国家药监局公布的第 31 批参比制剂目录中明确了利多卡因丁卡因乳膏参比制剂为美国橙皮书和欧盟上市的未进口原研药品，持证商分别是Taro Pharms 和 Difa Cooper SPA/Galderma Laboratorium GmbH。截至目前，该产品国内暂无上市。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377011.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"卫信康(603676.SH)：利多卡因丁卡因乳膏获药物临床试验批准","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0191","BK0239","603676"],"gpt_icon":0},{"id":"2585810680","title":"每周股票复盘：卫信康（603676）每股派现0.147元","url":"https://stock-news.laohu8.com/highlight/detail?id=2585810680","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585810680?lang=zh_cn&edition=full","pubTime":"2025-11-23 04:28","pubTimestamp":1763843292,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，卫信康报收于10.96元，较上周的11.73元下跌6.56%。本周，卫信康11月17日盘中最高价报11.74元。卫信康当前最新总市值47.69亿元，在化学制药板块市值排名102/151，在两市A股市值排名3344/5167。广东信达律师事务所出具法律意见书，确认本次差异化权益分派符合相关法律法规及公司章程规定，未损害上市公司和股东利益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300001285.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603676","BK0191"],"gpt_icon":0},{"id":"2584373956","title":"卫信康（603676）披露2025年前三季度权益分派实施公告，11月18日股价下跌0.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584373956","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584373956?lang=zh_cn&edition=full","pubTime":"2025-11-18 22:44","pubTimestamp":1763477056,"startTime":"0","endTime":"0","summary":"截至2025年11月18日收盘，卫信康报收于11.47元，较前一交易日下跌0.61%，最新总市值为49.91亿元。该股当日开盘11.49元，最高11.58元，最低11.41元，成交额达1714.44万元，换手率为0.34%。近日，西藏卫信康医药股份有限公司发布2025年前三季度权益分派实施公告。股权登记日为2025年11月25日，除权除息日与现金红利发放日均为2025年11月26日。本次合计拟派发现金红利63,553,215.60元（含税），占2025年前三季度归母净利润的29.00%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111800040290.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","603676","BK0239"],"gpt_icon":0},{"id":"2582786491","title":"每周股票复盘：卫信康（603676）拟每10股派1.47元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582786491","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582786491?lang=zh_cn&edition=full","pubTime":"2025-11-09 05:06","pubTimestamp":1762635978,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，卫信康报收于11.26元，较上周的11.15元上涨0.99%。本周，卫信康11月3日盘中最高价报11.35元。本周关注点来自机构调研要点：公司拟每10股派发现金股利1.47元（含税）。2025年第三季度，公司一次性补缴企业所得税及滞纳金合计2,185.81万元，本事项不涉及行政处罚。公司补缴上述税款及滞纳金全部计入2025年当期损益。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900001835.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0239","603676"],"gpt_icon":0},{"id":"2581011659","title":"股市必读：卫信康（603676）11月6日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2581011659","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581011659?lang=zh_cn&edition=full","pubTime":"2025-11-07 03:04","pubTimestamp":1762455853,"startTime":"0","endTime":"0","summary":"截至2025年11月6日收盘，卫信康报收于11.22元，上涨0.36%，换手率0.39%，成交量1.7万手，成交额1897.81万元。来自机构调研要点：公司多种微量元素注射液在多个省份集采中选，并完成接续采购。2025年第三季度，公司一次性补缴企业所得税及滞纳金合计2,185.81万元，该事项不涉及行政处罚，相关金额计入当期损益，不追溯调整前期财务数据。2025年9月至10月期间，该产品相继在京津冀“3+N”联盟接续采购、陕西十四省集采、广东联盟接续采购中中选。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110700002526.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","603676","BK0239"],"gpt_icon":0},{"id":"2580032844","title":"每周股票复盘：卫信康（603676）股东户数增14.14%，Q3净利降54.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580032844","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580032844?lang=zh_cn&edition=full","pubTime":"2025-11-02 09:56","pubTimestamp":1762048572,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，卫信康报收于11.15元，较上周的11.89元下跌6.22%。本周，卫信康10月28日盘中最高价报11.95元。卫信康当前最新总市值48.52亿元，在化学制药板块市值排名110/151，在两市A股市值排名3412/5163。股本股东变化截至2025年9月30日，公司股东户数为1.65万户，较6月30日增加2047户，增幅14.14%。其中第三季度主营收入2.76亿元，同比下降23.5%；单季度归母净利润3638.86万元，同比下降54.4%；扣非净利润3258.03万元，同比下降59.74%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200002213.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0239","603676"],"gpt_icon":0},{"id":"2579095521","title":"股市必读：卫信康（603676）10月30日收盘跌7.13%，主力净流出1080.49万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2579095521","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579095521?lang=zh_cn&edition=full","pubTime":"2025-10-31 06:21","pubTimestamp":1761862903,"startTime":"0","endTime":"0","summary":"截至2025年10月30日收盘，卫信康报收于10.94元，下跌7.13%，换手率1.88%，成交量8.19万手，成交额9065.98万元。当日关注点来自交易信息汇总：卫信康股价连续5日下跌，10月30日收盘报10.94元，跌幅7.13%。来自公司公告汇总：卫信康拟每10股派发现金股利1.47元（含税），合计派现63,553,215.60元（含税），占前三季度净利润的29.00%。前10个交易日主力资金累计净流出1884.1万元，同期股价累计下跌7.42%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100007935.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0239","603676"],"gpt_icon":0},{"id":"2579109502","title":"卫信康（603676）2025年三季报简析：净利润同比下降9.9%，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2579109502","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579109502?lang=zh_cn&edition=full","pubTime":"2025-10-31 06:20","pubTimestamp":1761862807,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期卫信康发布2025年三季报。截至本报告期末，公司营业总收入8.62亿元，同比下降13.27%，归母净利润2.19亿元，同比下降9.9%。按单季度数据看，第三季度营业总收入2.76亿元，同比下降23.5%，第三季度归母净利润3638.86万元，同比下降54.4%。本报告期卫信康盈利能力上升，毛利率同比增幅13.07%，净利率同比增幅3.88%。持有卫信康最多的基金为湘财医药健康混合A，目前规模为0.17亿元，最新净值1.6584，较上一交易日下跌0.9%，近一年上涨5.85%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100007875.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603676"],"gpt_icon":0},{"id":"2579711179","title":"图解卫信康三季报：第三季度单季净利润同比下降54.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579711179","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579711179?lang=zh_cn&edition=full","pubTime":"2025-10-29 18:53","pubTimestamp":1761735225,"startTime":"0","endTime":"0","summary":"证券之星消息，卫信康2025年三季报显示，前三季度公司主营收入8.62亿元，同比下降13.27%；归母净利润2.19亿元，同比下降9.9%；扣非净利润1.69亿元，同比下降14.01%；其中2025年第三季度，公司单季度主营收入2.76亿元，同比下降23.5%；单季度归母净利润3638.86万元，同比下降54.4%；单季度扣非净利润3258.03万元，同比下降59.74%；负债率20.06%，投资收益1161.36万元，财务费用-111.28万元，毛利率61.86%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900039610.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603676"],"gpt_icon":0},{"id":"2579920125","title":"卫信康(603676)9月30日股东户数1.65万户，较上期增加14.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579920125","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579920125?lang=zh_cn&edition=full","pubTime":"2025-10-29 17:19","pubTimestamp":1761729569,"startTime":"0","endTime":"0","summary":"证券之星消息，近日卫信康披露，截至2025年9月30日公司股东户数为1.65万户，较6月30日增加2047.0户，增幅为14.14%。在化学制药行业个股中，卫信康股东户数低于行业平均水平，截至9月30日，化学制药行业平均股东户数为3.38万户。从股价来看，2025年6月30日至2025年9月30日，卫信康区间涨幅为15.3%，在此期间股东户数增加2047.0户，增幅为14.14%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900035480.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0191","603676"],"gpt_icon":0},{"id":"2567139100","title":"每周股票复盘：卫信康（603676）2025年中期分红待定，上半年净利增11.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2567139100","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567139100?lang=zh_cn&edition=full","pubTime":"2025-09-14 06:14","pubTimestamp":1757801652,"startTime":"0","endTime":"0","summary":"截至2025年9月12日收盘，卫信康报收于12.44元，较上周的12.3元上涨1.14%。本周，卫信康9月9日盘中最高价报13.29元。来自机构调研要点：2025年上半年公司实现净利润1.83亿元，同比增长11.82%。来自公司公告汇总：多项公司治理制度于2025年9月完成修订并生效。答：2025年上半年，公司实现营业收入5.86亿元，同比下降7.43%；实现归母净利润1.83亿元，同比增长11.82%；扣非净利润1.37亿元，同比增长17.86%。董事会成员将由7人增至8人。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091400001609.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0191","603676"],"gpt_icon":0},{"id":"2563836282","title":"每周股票复盘：卫信康（603676）Q2净利增43.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563836282","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563836282?lang=zh_cn&edition=full","pubTime":"2025-08-31 10:29","pubTimestamp":1756607348,"startTime":"0","endTime":"0","summary":"截至2025年8月29日收盘，卫信康报收于12.33元，较上周的12.87元下跌4.2%。本周，卫信康8月27日盘中最高价报13.49元。本周关注点业绩披露要点：2025年第二季度归母净利润9824.69万元，同比上升43.33%。股本股东变化截至2025年6月30日，公司股东户数为1.45万户，较3月31日增加1170户，增幅8.79%。2025年第二季度单季度主营收入2.9亿元，同比下降7.94%；单季度归母净利润9824.69万元，同比上升43.33%；单季度扣非净利润6251.46万元，同比上升5.22%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083100003091.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603676","BK0191"],"gpt_icon":0},{"id":"2563983040","title":"股市必读：卫信康中报 - 第二季度单季净利润同比增长43.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563983040","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563983040?lang=zh_cn&edition=full","pubTime":"2025-08-29 07:51","pubTimestamp":1756425071,"startTime":"0","endTime":"0","summary":"来自：2025年第二季度归母净利润达9824.69万元，同比增长43.33%。股本股东变化股东户数变动近日卫信康披露，截至2025年6月30日公司股东户数为1.45万户，较3月31日增加1170.0户，增幅为8.79%。西藏卫信康医药股份有限公司2025年第二次临时股东大会会议资料西藏卫信康医药股份有限公司将于2025年9月12日召开2025年第二次临时股东大会，会议采用现场投票与网络投票相结合的方式。取消监事会后，监事会相关制度废止，由董事会审计委员会履行监事会职权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082900008321.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603676"],"gpt_icon":0},{"id":"2562729021","title":"图解卫信康中报：第二季度单季净利润同比增长43.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562729021","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562729021?lang=zh_cn&edition=full","pubTime":"2025-08-28 01:40","pubTimestamp":1756316455,"startTime":"0","endTime":"0","summary":"证券之星消息，卫信康2025年中报显示，公司主营收入5.86亿元，同比下降7.43%；归母净利润1.83亿元，同比上升11.82%；扣非净利润1.37亿元，同比上升17.86%；其中2025年第二季度，公司单季度主营收入2.9亿元，同比下降7.94%；单季度归母净利润9824.69万元，同比上升43.33%；单季度扣非净利润6251.46万元，同比上升5.22%；负债率20.89%，投资收益756.78万元，财务费用-100.15万元，毛利率61.61%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082800001453.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603676"],"gpt_icon":0},{"id":"2553207374","title":"卫信康：公司不涉及高反药相关业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2553207374","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553207374?lang=zh_cn&edition=full","pubTime":"2025-07-24 16:25","pubTimestamp":1753345513,"startTime":"0","endTime":"0","summary":"有投资者向卫信康提问， 董秘你好，请问公司是否涉及高反药的制造，销售等业务公司回答表示，尊敬的投资者您好！公司不涉及高反药相关业务。谢谢您的关注！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724164006971b9f14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724164006971b9f14&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0191","BK0239","603676"],"gpt_icon":0},{"id":"2551336431","title":"卫信康股价回调1.37% 化学制药板块成交额达1.84亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551336431","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551336431?lang=zh_cn&edition=full","pubTime":"2025-07-15 02:13","pubTimestamp":1752516785,"startTime":"0","endTime":"0","summary":"截至2025年7月14日收盘，卫信康股价报12.20元，较前一交易日下跌0.17元，跌幅1.37%。当日开盘价为12.31元，最高触及12.47元，最低下探至12.09元，成交量为15.10万手，成交额1.84亿元。卫信康属于化学制药板块，同时涉及西藏板块、维生素、婴童概念等细分领域。公司专注于医药制造与研发，产品涵盖维生素及矿物质补充剂等领域。7月14日早盘，卫信康股价曾快速回调，5分钟内跌幅超过2%，盘中最低报12.12元，成交额3620.54万元。当日主力资金净流出1397.28万元。风险提示：股市有风险，投资需谨慎。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071502193795426885&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071502193795426885&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603676","BK0239","BK0191"],"gpt_icon":0},{"id":"2551916840","title":"每周股票复盘：卫信康（603676）因价格振幅达15%再次上榜龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2551916840","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551916840?lang=zh_cn&edition=full","pubTime":"2025-07-13 01:59","pubTimestamp":1752343148,"startTime":"0","endTime":"0","summary":"截至2025年7月11日收盘，卫信康报收于12.37元，较上周的12.68元下跌2.44%。本周，卫信康7月9日盘中最高价报14.94元，股价触及近一年最高点。本周关注点交易信息汇总：卫信康因价格振幅达到15%再次登上龙虎榜交易信息汇总沪深交易所2025年7月8日公布的交易公开信息显示，卫信康因有价格涨跌幅限制的日价格振幅达到15%的前五只证券登上龙虎榜。此次是近5个交易日内第2次上榜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071300000230.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603676","BK0191","BK0239"],"gpt_icon":0},{"id":"2550393861","title":"卫信康：公司将进一步增强自主创新研发能力，加强技术积累，形成差异化、高壁垒的产品群","url":"https://stock-news.laohu8.com/highlight/detail?id=2550393861","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550393861?lang=zh_cn&edition=full","pubTime":"2025-07-11 16:06","pubTimestamp":1752221160,"startTime":"0","endTime":"0","summary":"有投资者向卫信康提问， 公司目前在研药有没有国内目前还没有的药品？谢谢公司回答表示，尊敬的投资者您好！公司在研产品情况详见《2024年年度报告》中“第三节 管理层讨论与分析”之“一、经营情况讨论与分析”。在研发方面，公司将进一步增强自主创新研发能力，加强技术积累，在优势领域深挖护城河，形成差异化、高壁垒的产品群；发掘新的差异化细分赛道产品，践行“上市一批，储备一批，在研一批，立项一批”的研发思路；积极探索与国内外科研机构的合作模式，逐步积累培养做创新药的能力和储备产品。谢谢您的关注！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711162823a44457e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711162823a44457e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603676","BK0191"],"gpt_icon":0},{"id":"2550646404","title":"卫信康：公司始终坚持关爱生命维护健康的企业使命","url":"https://stock-news.laohu8.com/highlight/detail?id=2550646404","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550646404?lang=zh_cn&edition=full","pubTime":"2025-07-10 16:00","pubTimestamp":1752134400,"startTime":"0","endTime":"0","summary":"有投资者向卫信康提问， 天水幼儿事件，铅中毒，排铅的同时，身体的微量元素也会被一起排出，这就需要外部来补充营养，我公司维生素具有先进水平，可否对于特定事件，赞助或者给当地指导支持一下，因为铅中毒是终生的，同时得终生服用维生素，希望贵司能秉承大无畏精神，帮助病患幼儿早日康复！谢谢万分感谢公司回答表示，尊敬的投资者您好！感谢您的建议！公司始终坚持“关爱生命，维护健康”的企业使命，密切关注社会动态，并结合自身专长，积极履行社会责任。谢谢您的关注！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710161237a4421270&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710161237a4421270&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0191","603676","BK0239"],"gpt_icon":0},{"id":"2550530611","title":"卫信康：2025年中期利润分配方案将根据条件制定","url":"https://stock-news.laohu8.com/highlight/detail?id=2550530611","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550530611?lang=zh_cn&edition=full","pubTime":"2025-07-10 15:57","pubTimestamp":1752134237,"startTime":"0","endTime":"0","summary":"证券之星消息，卫信康07月10日在投资者关系平台上答复投资者关心的问题。谢谢卫信康回复：尊敬的投资者您好！公司将按照《上海证券交易所股票上市规则》关于业绩预告的相关规定履行信息披露义务。2025年5月16日，公司召开股东大会审议通过了《关于提请股东大会授权董事会制定2025年中期利润分配方案的议案》，董事会将在满足一定条件的前提下，制定2025年中期利润分配方案，具体以后续公告为准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071000023081.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0239","603676"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765796047991,"stockEarnings":[{"period":"1week","weight":-0.0435},{"period":"1month","weight":-0.0595},{"period":"3month","weight":-0.123},{"period":"6month","weight":-0.0028},{"period":"1year","weight":-0.0014},{"period":"ytd","weight":0.114}],"compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0277},{"period":"3month","weight":0.0048},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1236},{"period":"ytd","weight":0.1604}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"西藏卫信康医药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"16525人(较上一季度增加14.14%)","perCapita":"26333股","listingDate":"2017-07-21","address":"西藏自治区拉萨市堆龙德庆区经济技术开发区B区园区南路5号工业中心4号楼3层","registeredCapital":"43516万元","survey":" 西藏卫信康医药股份有限公司的主营业务是化学药品制剂及其原料药的研发、生产、销售。公司的主要产品是注射用多种维生素（12）、多种微量元素注射液、小儿多种维生素注射液（13）。","listedPrice":5.53},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"卫信康(603676)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供卫信康(603676)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"卫信康,603676,卫信康股票,卫信康股票老虎,卫信康股票老虎国际,卫信康行情,卫信康股票行情,卫信康股价,卫信康股市,卫信康股票价格,卫信康股票交易,卫信康股票购买,卫信康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"卫信康(603676)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供卫信康(603676)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}